Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
PPAR Research · 14.10.2021 · 2021 · 1-17
DOI: 10.1155/2021/6661181 ↗Kurz gefasst
Fachartikel in der Zeitschrift PPAR Research, erschienen am 14.10.2021. Verfasst von Sheryar Afzal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, MAHSA University, Selangor, Malaysia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Postgraduate Studies, Universiti Sains Malaysia, Universiti Sains Malaysia.
Abstract (Originalsprache)
Oxidative stress, which is associated with metabolic and anthropometric perturbations, leads to reactive oxygen species production and decrease in plasma adiponectin concentration. We investigated pharmacodynamically the pathophysiological role and potential implication of exogenously administered adiponectin with full and partial peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists on modulation of oxidative stress, metabolic dysregulation, and antioxidant potential in streptozotocin-induced spontaneously hypertensive rats (SHR). Group I (WKY) serves as the normotensive control, whereas 42 male SHRs were randomized equally into 7 groups ( n = 6 ); group II serves as the SHR control, group III serves as the SHR diabetic control, and groups IV, V, and VI are treated with irbesartan (30 mg/kg), pioglitazone (10 mg/kg), and adiponectin (2.5 μg/kg), whereas groups VII and VIII received cotreatments as irbesartan+adiponectin and pioglitazone+adiponectin, respectively. Diabetes was induced using an intraperitoneal injection of streptozotocin (40 mg/kg). Plasma adiponectin, lipid contents, and arterial stiffness with oxidative stress biomarkers were measured using an in vitro and in vivo analysis. Diabetic SHRs exhibited hyperglycemia, hypertriglyceridemia, hypercholesterolemia, and increased arterial stiffness with reduced plasma adiponectin and antioxidant enzymatic levels ( P < 0.05 ). Diabetic SHRs pretreated with pioglitazone and adiponectin separately exerted improvements in antioxidant enzyme activities, abrogated arterial stiffness, and offset the increased production of reactive oxygen species and dyslipidemic effects of STZ, whereas the blood pressure values were significantly reduced in the irbesartan-treated groups (all P < 0.05 ). The combined treatment of exogenously administered adiponectin with full PPAR-γ agonist augmented the improvement in lipid contents and adiponectin concentration and restored arterial stiffness with antioxidant potential effects, indicating the degree of synergism between adiponectin and full PPAR-γ agonists (pioglitazone).
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, Faculty of Pharmacy, MAHSA University, Selangor, Malaysia.
- School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia.
ORCID-Profile: Sheryar Afzal, Munavvar Abdul Sattar, Olorunfemi A Eseyin, Ali Attiq
Förderung
- Institute of Postgraduate Studies, Universiti Sains Malaysia
- Universiti Sains Malaysia
Zitieren
APA
Afzal, S., Sattar, M. A., Johns, E. J., Eseyin, O. A., & Attiq, A. (2021). Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats. PPAR Research, 2021, 1-17. https://doi.org/10.1155/2021/6661181
Vancouver
Afzal S, Sattar MA, Johns EJ, Eseyin OA, Attiq A. Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats. PPAR Research. 2021;2021:1-17. doi:10.1155/2021/6661181
BibTeX
@article{Afzal2021,
author = {Afzal, Sheryar and Sattar, Munavvar Abdul and Johns, Edward James and Eseyin, Olorunfemi A and Attiq, Ali},
title = {Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats},
journal = {PPAR Research},
year = {2021},
volume = {2021},
pages = {1--17},
doi = {10.1155/2021/6661181}
}
EUVIMED